About Matthew T.
Matthew T. Browne is a licensed attorney admitted to practice law in both California and New York. He was admitted to the New York State Bar in 1996 and to the California State Bar in 2000. Mr. Browne holds in California and is currently in active status. He is a partner at Cooley LLP, a global law firm with offices in San Diego, California, and New York, New York. His practice primarily focuses on corporate and securities matters, serving clients across various industries, including software, cybersecurity, healthcare, semiconductors, financial services, financial technology, consumer products, medical devices, diagnostics, and biotechnology. Mr. Browne's office is located at 4401 Eastgate Mall, San Diego, CA 92121-1909.
Mr. Browne earned his Juris Doctor degree, cum laude, from Harvard Law School in 1995. Prior to law school, he completed his undergraduate education at Yale University, graduating summa cum laude with a Bachelor of Arts degree in Economics and Political Science in 1990. During his time at Yale, he was elected to Phi Beta Kappa, recognizing his academic excellence. At Harvard, he graduated cum laude, indicating his strong academic performance.
Mr. Browne's practice areas encompass public finance and tax-exempt finance, corporate and incorporation matters, emerging growth companies, public offerings, debt securities transactions, and mergers and acquisitions. He represents both emerging and late-stage private companies, as well as public companies, in a wide range of corporate and securities matters. His experience spans corporate formation and governance, private financings, mergers and acquisitions, SPAC transactions, public company reporting and disclosure, public offerings, strategic collaborations, commercial agreements, and employment and compensation arrangements. He counsels management teams and boards at every stage of the business lifecycle, helping them achieve their goals in a constructive, practical, and creative manner.
Throughout his career, Mr. Browne has handled numerous significant transactions, including the de-SPAC transaction of Billtrust with South Mountain Merger Corp., the sale of XMatters to Everbridge, and the $44 million Series C financing of AttackIQ. He has also been involved in the sale of Paradigm Diagnostics and Viomics to Exact Sciences, the sale of Verb Surgical to Johnson & Johnson, and the sale of Kadcyla royalties to TPG Sixth Street Partners. Additionally, he represented MedImpact in a cash tender offer for all outstanding equity held by non-affiliates. His extensive experience includes all stages of litigation, from initial case evaluation to trial proceedings in both state and federal courts.
Mr. Browne is an active member of the American Bar Association and the New York State Bar Association. He serves on the board of directors and executive committee of the Corporate Directors Forum and the executive committee of Connect San Diego. He is also a former trustee of the Sanford Burnham Prebys Medical Discovery Institute. At Cooley, he is a member of the risk management committee and has previously served on the opinion committee and partnership nominating committee. He is fluent in English and has a working knowledge of Spanish, allowing him to serve a diverse clientele effectively.
